Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.7150
+0.0450 (2.69%)
NASDAQ · Last Trade: Jan 12th, 3:56 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors